At-Methylene Blue for Targeted Radiotherapy of Human Melanoma Xenografts: Treatment of Cutaneous Tumors and Lymph Node Metastases

Cancer Research

Volumn 52, Issue 16, 1992, Pages 4385-4390

  Carpenter, Robert N ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASTATINE; DIAGNOSTIC AGENT; METHYLENE BLUE; ASTATINE 211;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL CULTURE; DRUG SCREENING; FEMALE; HUMAN; LYMPH NODE METASTASIS; MELANOMA; MOUSE; NUDE MOUSE; PATHOLOGY; SKIN TUMOR; VASCULARIZATION; XENOGRAFT; ANIMAL EXPERIMENT; CONTROLLED STUDY; GROWTH INHIBITION; GROWTH RATE; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; NONHUMAN; PIGMENTATION; PRIORITY JOURNAL; RADIOTHERAPY; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; ASTATINE; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; LYMPHATIC METASTASIS; MELANOMA; METHYLENE BLUE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; SKIN NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0026612543     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Humm, J. L. Dosimetric aspects of radiolabelled antibodies for tumour therapy. J. Nucl. Med., 27:422-427, 1986.
2. Link, E. M., and Rydzy, M. Endoirradiation of neoplastic tissues by administered radioisotopes. In: Proceedings of the Third Meeting of the Polish Biophysics Society, Vol. 1, p. 62. 1978.
3. Link, E. M., and Lukiewicz, S. A new radioactive drug selectively accumulating in melanoma cells. Eur. J. Nucl. Med., 7: 469-473, 1982.
4. Link, E. M., Brown, I., Carpenter, R. N., and Mitchell, J. S. Uptake and therapeutic eflectiveness of 125I and 211At-methylene blue for pigmented melanoma in an animal model system. Cancer Res., 49: 4332-4337, 1989.
5. Potts, A. M. The reaction of uveal pigment in vitro with polycyclic compounds. Invest. Opthalmol. Visual Sci., 3:405-416, 1964.
6. Reynolds, J. E. F. (ed.). Martindale-The Extra Pharmacopoeia, Ed. 28, pp. 384-385. London: The Pharmaceutical Press, 1982.
7. Link, E. M., and Carpenter, R. N. 211At-Methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of micrometastases. Cancer Res., 50: 2963-2967, 1990.
8. Smith, I. E., Courtenay, D., Mills, J., and Peckham, M. J. In vitro radiation response of cells from four human tumors propagated in immune-suppressed mice. Cancer Res., 38: 390-392, 1978.
9. West, C. M. L., Sandhu, R. R., and Stratford, I. J. The radiation response of V79 and human tumour multicellular spheroids-cell survival and growth delay studies. Br. J. Cancer, 50: 143-151, 1984.
10. Brown, I., Carpenter, R. N., Link, E. M., and Mitchell, J. S. Potential diagnostic and therapeutic agents for malignant melanoma: synthesis of heavy radiohalogenated derivatives of methylene blue by electrophilic and nucleophilic methods. J. Radioanal. Nucl. Chem., 107: 337-351, 1986.
11. Schreck, R. A. A quantitative study of the growth of the Walker rat tumor and the Flexner-Jobling rat carcinoma. Am. J. Cancer, 28: 345-363, 1936.
12. Cobb, L. M., Harrison, A., and Butler, S. A. Toxicology of astatine-211 in the mouse. Hum. Toxicol., 7: 529-534, 1988.
13. Baker, F. J., and Silverton, R. E. (eds.). Introduction to Medical Laboratory Technology, pp. 299-426. London: Butterworth Scientific, 1976.
14. Lukiewicz, S., Pilas, B., Nowicka, J., Cieszka, K., and Gurbiel, R. Molecular and cellular basis of different radiosensitivity in pigmented and nonpigmented hamster melanoma cells. In: Seiji, M. (ed.). Phenotypic Expression in Pigment Cells, Proceedings of the Eleventh International Pigment Cell Conference, pp. 647-653. Tokyo: Tokyo University Press, 1980.